diabetic retinopathy

By Dave Muoio 02:18 pm July 10, 2019
Virtual until proven fraudulent. A New York anesthesiologist has been indicted for her role in a scheme to submit fraudulent telemedicine claims to Medicare, Medicare Part D plans as we. According to the indictment, Dr. Anna Steiner and other providers purported to practice telemedicine in exchange for kickbacks starting in 2015. This resulted in more than $7 million in Medicare claims on behalf...
By Dave Muoio and Jonah Comstock 03:06 pm May 1, 2019
Wearables, services perform well for Apple. While iPhone sales and overall Q2 revenue were down in 2019, the company was fairly optimistic on its most recent earnings report due to substantial growth among its wearables, iPads and services businesses. In terms of healthcare, CEO Tim Cook noted during the investors’ call that the past quarter included the rollout of the Apple Watch Series 4’s ECG...
By Laura Lovett 03:23 pm February 25, 2019
Google has been busy recently. Just in the past week it has closed down its Google Fit website,  launched a new drug disposal tool and announced the first clinical use of Verily’s machine learning tool for diabetic related diseases.  Below is a look at three of the company’s digital health announcements in the last week.  Addressing the opioid crisis  It started last Wednesday when Google...
By Dave Muoio 03:17 pm August 28, 2018
Pivotal trial data that led to April’s de novo clearance of the first AI-based diagnostic system to not require clinician interpretation is now available to the public. Published today in npj Digital Medicine, this 900-patient investigation showed that the IDx-Dr system for autonomous detection of diabetic retinopathy “robustly exceeded the pre-specified primary endpoint goals” and is able to...
By Dave Muoio 04:21 pm May 9, 2018
Google has unleashed a tidal wave of product and feature updates through the ongoing Google I/O developers’ conference, and it’s no surprise that the intersection of artificial intelligence and healthcare was a recurring spotlight among them. Through keynote speeches and simultaneously released online blog posts, the company highlighted a handful of tech-driven healthcare efforts that seem to be...
By Dave Muoio 11:10 am April 12, 2018
The FDA has granted diagnostics company IDx’s De Novo request to market its AI-based software system for the autonomous detection of diabetic retinopathy in adults who have diabetes, called IDx-DR. This decision represents the first AI-based diagnostic system authorized by the FDA for commercialization in the US that can provide a screening decision without the need for clinician interpretation,...
By Laura Lovett 03:58 pm March 14, 2018
 In new study published in Ophthalmology,  Google AI researchers found that they could improve their AI disease detecting software by using a small subset of images adjudicated by ophthalmologists that specialize in retinal diseases. "We believe this work provides a basis for further research and raises the bar for reference standards in the field of applying machine learning to medicine," Dr....
By Laura Lovett 03:06 pm March 12, 2018
Worldwide there are 422 million people living with diabetes, according to World Health Organization estimates. The condition can lead complications, including diabetic retinopathy, which can result in blindness. However, a recent study suggests artificial intelligence can help identify diabetic retinopathy early. Researchers at the Medras Diabetes Research foundation in Chennai India found that a...
By Jeff Lagasse 02:45 pm August 8, 2017
Kavya Kopparapu might be considered something of a “whiz kid.” After all, she had yet to enter her senior year of high school when she started Eyeagnosis, a smartphone app and 3D-printed lens that allows patients to be screened for diabetic retinopathy with a quick photo, avoiding the time and expense of a typical diagnostic procedure.   In June 2016, Kopparapu’s grandfather had recently been...
By Heather Mack 05:20 pm April 24, 2017
Out of the 422 million people around the world living with diabetes, one in three of them will develop diabetic retinopathy (DR), a common condition that can lead to permanent blindness if left untreated. While early detection and treatment can dramatically reduce that risk, a third of people with diabetes have never even been screened for DR, as many are living in low-income, medically...